PatentSight Free Webinar

Where do we stand in fighting pandemics caused by bacteria?

A closer look into the patent landscape of antibiotics


June 25th 2020 | 18:00 CET | 12:00 pm (noon) ET


Looking at the patent landscape of antibiotics to identify global leaders



About the Webinar

As the global research community is scrambling to develop solutions and help the world recover from the impact of Covid-19, we should not stay blind to other medical risks on the horizon which should be addressed. Chief among these is drug resistant bacteria, a risk which could potentially lead to almost an equal impact as by the current pandemic.

Tuberculosis for e.g. is a global disease caused by bacterial infection, found in almost every country in the world. It is the leading (infectious) cause of death worldwide, killing someone approximately every 21 seconds — for reference, about 1.5 million deaths in 2018 alone; compared to the approximately 450,000 deaths due to the Covid-19 virus in the last 6 months. Consuming antibiotics at a higher rate is not a sustainable solution as the research community has observed an increase in the evolution of drug resistant strains of bacteria, that has been linked to excessive use of such anti-bacterial drugs.

In the US alone, in 2012, animals consumed more than twice as many medically important antibiotics as humans. Such a heavy dependency and use of anti-bacterial drugs often lead to an increasing number of antibiotic-resistant bacteria like some strains of E.Coli, etc. or antimicrobial resistance (AMR) with multiple or totally resistant pathogens.

We take a look at the patent landscape of antibiotics to identify global leaders developing the latest innovation in this technology. Join our webinar to find out which company/companies own the strongest patents in this field, and thus are prepared to save the world from a drug resistant bacteria, if it comes  to that.

Using our proven metrics, in this webinar, the presenters will examine and discuss: 

  • an overview analysis of the antibiotics patent landscape in general
  • an overview analysis of the antibiotics patent landscape for the World Health Organisation (WHO) list of antibiotic-resistant priority pathogens
  • and, a look at companies that recently gained market authorization for new antibiotics 

In addition, experience how the powerful visualization features offered by PatentSight, help to quickly identify the strongest players in any specific IP landscape.



This Webinar would be especially interesting for:

  • IP professionals
  • R&D executives
  • Competitive intelligence experts

At Pharmaceutical and Drug manufacturing organizations with international business growth strategies.

Register for this Webinar


Gene Quinn
Gene Quinn

Gene Quinn is the President and founder of, a patent attorney, law professor, and leading commentator on patent law and innovation policy. Gene’s writing typically focuses on pending legislation, rule making at the United States Patent and Trademark Office, and general commentary about the state of the industry. Gene practices patent law with Widerman Malek, and the majority of his patent practice is focused on software patents and Internet innovations. Since 2000 he has also been a principal lecturer in the PLI Patent Bar Review Course.




An IP  insider from a leading pharma company
Dirk Caspary
Senior Consultant
PatentSight® - A LexisNexis Company

Dr. Dirk Caspary is a Senior Consultant at PatentSight. His strong analytical skills in combination with his 'outside-the-box' thinking, give Dirk's clients an edge over their competitors. His academic background in chemistry and a focus on physical chemistry of solids, led him to work for five years in the semiconductor industry and more than a decade as a senior process analyst and IP consultant before joining PatentSight.

Register for this Webinar

Drug resistant bacterial diseases - how prepared is the world?

June 25th 2020 | 18:00 CET | 12:00 pm (noon) ET

Please fill up the adjacent form and click on submit to register for the webinar. Shortly after this, you will receive an email registration confirmation from 'GoToWebinar'. This email will also contain further information regarding the procedure to join the webinar, links to download presentation material, etc.
If you did not receive a registration confirmation email from 'GoToWebinar' or have any other questions regarding this webinar, please contact us at: 
Please note: If you are unable to attend the live webinar session, we will send you a link to the recording, so you can watch at your convenience. Make sure to register for the webinar, only then can we send you the link by email.